Related Experiment Video
Updated: Jun 10, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
[Chronic coronary syndrome in patients with non-obstructive coronary arteries]
Ann Rantzau Kjær Pedersen1, Salma Karim1,2, Ashkan Eftekhari3
1Hjertesygdomme, Regionshospitalet Viborg.
Insights
Ischaemia with non-obstructive coronary arteries (INOCA) is often missed, particularly in women, leading to reduced quality of life. Diagnosis and tailored treatments based on INOCA endotype significantly improve patient outcomes.
Area of Science:
- Cardiology
- Vascular Medicine
- Diagnostic Imaging
Background:
- Chronic coronary syndrome frequently presents as chest pain.
- Ischaemia with non-obstructive coronary arteries (INOCA) is underdiagnosed and disproportionately affects women.
- INOCA patients experience diminished quality of life and increased risk of major adverse cardiac events.
Purpose of the Study:
- To review the diagnosis and management of INOCA.
- To highlight the importance of identifying INOCA endotypes.
- To summarize treatment strategies that improve quality of life.
Main Methods:
- Literature review focusing on INOCA diagnosis and treatment.
- Analysis of studies involving invasive functional testing for INOCA.
- Evaluation of pharmacological and non-pharmacological treatment approaches.
Main Results:
- INOCA symptoms stem from endothelial dysfunction, microvascular disease, or vasospastic disease.
- Invasive functional testing is crucial for accurate diagnosis and endotyping.
- Treatment guided by INOCA endotype improves patient quality of life.
Conclusions:
- Accurate diagnosis and endotyping of INOCA are essential.
- Multifaceted treatment strategies, tailored to the endotype, are effective.
- Improving quality of life is a key outcome in INOCA management.
Abstract:
Chronic coronary syndrome is a common cause of chest pain. Ischaemia with non-obstructive coronary arteries (INOCA) is underdiagnosed and more frequent in women. Patients with INOCA have a lower quality of life and a higher risk of major adverse cardiac events. Symptoms arise from endothelial dysfunction, microvascular disease, vasospastic disease or a combination. Invasive functional testing is important to secure the diagnosis and endotype of the patient. This review finds that the treatment is both pharmacological and non-pharmacological and is guided by endotype of INOCA and has shown improved quality of life.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care
Angina II: Classification
Acute Coronary Syndrome V: Nursing Management

